Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment.

Song SH, Gray TA.

QJM. 2012 Oct;105(10):973-80. Epub 2012 Jun 28.

PMID:
22753665
[PubMed - indexed for MEDLINE]
Free Article
2.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
[PubMed - indexed for MEDLINE]
3.

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.

Clin Ther. 2004 Sep;26(9):1388-99. Erratum in: Clin Ther. 2005 Jan;27(1):142.

PMID:
15531001
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.

Jones PH, Cusi K, Davidson MH, Kelly MT, Setze CM, Thakker K, Sleep DJ, Stolzenbach JC.

Am J Cardiovasc Drugs. 2010;10(2):73-84. doi: 10.2165/10061630-000000000-00000.

PMID:
20136164
[PubMed - indexed for MEDLINE]
5.

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).

Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN.

Clin Chem. 2009 Mar;55(3):473-80. doi: 10.1373/clinchem.2008.111401. Epub 2009 Jan 15.

PMID:
19147732
[PubMed - indexed for MEDLINE]
Free Article
6.

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

Clin Ther. 2004 Mar;26(3):379-89.

PMID:
15110130
[PubMed - indexed for MEDLINE]
7.

Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.

Katulanda GW, Katulanda P, Adler AI, Peiris SR, Draisey I, Wijeratne S, Sheriff R, Matthews DR, Shine B.

Ann Clin Biochem. 2010 Jan;47(Pt 1):29-34. doi: 10.1258/acb.2009.009080. Epub 2009 Dec 1.

PMID:
19952033
[PubMed - indexed for MEDLINE]
8.

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.

Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP.

Expert Opin Ther Targets. 2009 Jul;13(7):743-51. doi: 10.1517/14728220903023866.

PMID:
19505224
[PubMed - indexed for MEDLINE]
9.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

PMID:
20550659
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].

Pérez A, González Blanco C, Hernández-Presa MÁ, Chaves J.

Endocrinol Nutr. 2011 Jun-Jul;58(6):283-90. doi: 10.1016/j.endonu.2011.03.005. Spanish.

PMID:
21641286
[PubMed - indexed for MEDLINE]
11.

Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.

Drexel H, Aczel S, Marte T, Vonbank A, Saely CH.

Atherosclerosis. 2010 Feb;208(2):484-9. doi: 10.1016/j.atherosclerosis.2009.08.026. Epub 2009 Aug 21.

PMID:
19748621
[PubMed - indexed for MEDLINE]
12.

Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus.

Galvano F, Li Volti G, Malaguarnera M, Avitabile T, Antic T, Vacante M, Malaguarnera M.

Expert Opin Pharmacother. 2009 Aug;10(12):1875-82. doi: 10.1517/14656560903081745.

PMID:
19618992
[PubMed - indexed for MEDLINE]
13.

Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles.

O'Neal DN, Piers LS, Iser DM, Rowley KG, Jenkins AJ, Best JD, O'Dea K.

Atherosclerosis. 2008 Dec;201(2):368-77. doi: 10.1016/j.atherosclerosis.2008.03.022. Epub 2008 Apr 6.

PMID:
18599067
[PubMed - indexed for MEDLINE]
14.

Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.

Tan CE, Chew LS, Chio LF, Tai ES, Lim HS, Lim SC, Jayakumar L, Eng HK, Packard CJ.

Diabetes Res Clin Pract. 2001 Feb;51(2):107-14.

PMID:
11165690
[PubMed - indexed for MEDLINE]
15.

Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.

Hummel J, Westphal S, Weber-Hamann B, Gilles M, Lederbogen F, Angermeier T, Luley C, Deuschle M, Kopf D.

J Clin Psychiatry. 2011 Jul;72(7):885-91. doi: 10.4088/JCP.09m05853blu. Epub 2011 Jan 25.

PMID:
21294998
[PubMed - indexed for MEDLINE]
16.

Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.

Meas T, Laloi-Michelin M, Virally M, Peynet J, Giraudeaux V, Kévorkian JP, Guillausseau PJ.

Eur J Intern Med. 2009 Mar;20(2):197-200. doi: 10.1016/j.ejim.2008.06.009. Epub 2008 Aug 15.

PMID:
19327612
[PubMed - indexed for MEDLINE]
17.

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.

Farrer M, Winocour PH, Evans K, Neil HA, Laker MF, Kesteven P, Alberti KG.

Diabetes Res Clin Pract. 1994 Mar;23(2):111-9.

PMID:
8070302
[PubMed - indexed for MEDLINE]
18.

Apolipoprotein and lipid ratios in treated non-insulin dependent diabetics.

Dean JD, Owens DR, Matthews SB.

Diabetes Res. 1990 Sep;15(1):21-5.

PMID:
2132196
[PubMed - indexed for MEDLINE]
19.
20.

Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.

Posadas-Sánchez R, Posadas-Romero C, Mendoza-Pérez E, Caracas-Portilla NA, Cardoso-Saldaña G, Medina-Urrutia A, Jorge-Galarza E, Juárez-Rojas JG.

Am J Cardiol. 2012 Mar 1;109(5):636-41. doi: 10.1016/j.amjcard.2011.10.017. Epub 2011 Dec 9.

PMID:
22169129
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk